Related Experiment Video
Updated: Mar 25, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
Acute encephalitis with refractory, repetitive partial seizures: Pathological findings and a new therapeutic approach
Yuko Sato1, Yurika Numata-Uematsu1, Mitsugu Uematsu1
1Department of Pediatrics, Tohoku University School of Medicine, Sendai, Japan.
Abstract:
Acute encephalitis with refractory, repetitive partial seizures (AERRPS) is characterized by prolonged severe seizures and a high-grade fever. We experienced a boy with severe AERRPS with frequent partial seizures that exhibited right-side predominance. The patient required the continuous intravenous administration of many antiepileptic drugs and respirator management for several months. Methylprednisolone pulse therapy and intravenous immunoglobulin administration were only temporarily effective. The MRI and EEG showed the abnormality in the left occipital lobe. Although occipital lobectomy was performed, his seizures continued. His cerebrospinal fluid exhibited elevated protein and proinflammatory cytokine levels, and was positive for anti-glutamate receptor ε2 antibodies. Pathological examination showed infiltration of many neutrophilic leukocytes, T cells, and microglia in the area exhibiting severe spongiosis. We thought that the exaggerated microglia and T-cell responses were related to the pathogenesis of the patient's seizures, and we therefore initiated treatment with tacrolimus. As a result, many of the daily seizure clusters were ameliorated, and the patient was discharged. We attempted to discontinue the tacrolimus twice, but the patient's seizure clusters recurred each time. This is the first case report of the pathological findings of AERRPS and showing an effective therapeutic approach using tacrolimus. Tacrolimus may be an effective immunosuppressant, especially for patients with severe AERRPS.
Insights
This case report details a severe form of acute encephalitis with refractory, repetitive partial seizures (AERRPS). Tacrolimus effectively managed seizures by targeting T-cell and microglia responses, offering a new therapeutic avenue.
Area of Science:
- Neuroimmunology
- Epileptology
Background:
- Acute encephalitis with refractory, repetitive partial seizures (AERRPS) presents with severe, prolonged seizures and fever.
- Standard treatments and even surgical intervention were ineffective in a severe pediatric case.
Observation:
- A pediatric patient with severe AERRPS exhibited right-sided partial seizures, requiring prolonged intensive care.
- Cerebrospinal fluid analysis revealed elevated protein, proinflammatory cytokines, and anti-glutamate receptor ε2 antibodies.
- Pathology showed significant microglial and T-cell infiltration with spongiosis in the affected brain region.
Findings:
- Tacrolimus treatment led to significant amelioration of daily seizure clusters.
- Seizure recurrence upon tacrolimus discontinuation highlights its therapeutic role.
- This report provides the first pathological insights into AERRPS and demonstrates tacrolimus efficacy.
Implications:
- Tacrolimus shows promise as an effective immunosuppressive therapy for severe AERRPS.
- Targeting T-cell and microglia-mediated inflammation may be crucial for managing AERRPS.
- This case expands therapeutic options for refractory epilepsy associated with autoimmune encephalitis.
More Related Videos
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
09:39Direct-current Stimulation and Multi-electrode Array Recording of Seizure-like Activity in Mice Brain Slice Preparation
Published on: June 7, 2016